KITE PHARMA, INC.
FDA inspection history in EL SEGUNDO, California, 2017 to 2021
- 3
- Form 483s
Every document, by year
- Form 483
2017: one Form 483; 2019: one Form 483; 2021: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2017–21Three Form 483s, at EL SEGUNDO, California.
- 2017The longest 483 on file: 4 observations over 3 pages at EL SEGUNDO, California.
Cited most
Across all KITE PHARMA observations on file
- 21 CFR 211.100Written procedures; deviations2
- 21 CFR 211.113Control of microbiological contamination1
- 21 CFR 211.165(e)Testing and release for distribution1
- 21 CFR 211.22Responsibilities of quality control unit1
- 21 CFR 211.42(c)(10)(iv)Design and construction features1
The complete KITE PHARMA file.
All 3 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
EL SEGUNDO, California
Three Form 483s · 2017 to 2021 · 9 observations
Latest: Form 483, Oct 22, 2021 →
Documents
3 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2021-10-22 | 483 Form 483 | EL SEGUNDO, California | 2 | $99 |
| 2019-08-20 | 483 Form 483 | EL SEGUNDO, California | 3 | $99 |
| 2017-06-16 | 483 Form 483 | EL SEGUNDO, California | 4 | $99 |
Investigators on these documents
FEI number 3012583739 · most recent document Oct 22, 2021
About KITE PHARMA, INC.
How many FDA Form 483s has KITE PHARMA, INC. received?
FDA Intel has 3 Form 483s on file for KITE PHARMA, INC.; the most recent is dated Oct 22, 2021.
When was KITE PHARMA, INC. last inspected by FDA?
The most recent FDA inspection document on file for KITE PHARMA, INC. is a Form 483 dated Oct 22, 2021, for the site in EL SEGUNDO, California.
What did FDA cite at KITE PHARMA, INC.?
The regulations cited most in the observations on file for KITE PHARMA, INC. are 21 CFR 211.100 (Written procedures; deviations), 2 times; 21 CFR 211.113 (Control of microbiological contamination), 1 time; 21 CFR 211.165(e) (Testing and release for distribution), 1 time.